The MRD Testing Collaborative is a collaborative group of stakeholders working to increase awareness of and access to MRD testing in a broad range of blood cancers including CLL. At the ASH (American Society of Hematology) annual meeting last year, Dr. Koffman and others were interviewed for the Be MRD Aware efforts as MRD testing begins a transition from a research tool to becoming an important aid in guiding patient decisions. Please enjoy these two short videos addressing the importance of MRD testing and possible barriers to access.
Originally published in The CLL Society Tribune MRD Special Edition.
